In this large prospective cohort study of 495,942 UK adults, we found that glucosamine use was associated with a 10% lower risk of dementia, there were significant additive and multiplicative interactions between glucosamine use and APOE ε4 genotype. This evidence concerns the gene APOE and dementia.